Mainz Biomed NV
F:4TO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mainz Biomed NV
F:4TO
|
DE |
|
Cryosite Ltd
ASX:CTE
|
AU |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
|
C
|
China National Complete Plant Import & Export Corp Ltd
SZSE:000151
|
CN |
|
Qingdao Eastsoft Communication Technology Co Ltd
SZSE:300183
|
CN |
|
Escorts Kubota Ltd
BSE:500495
|
IN |
|
Aimia Inc
TSX:AIM
|
CA |
|
G
|
Goyal Aluminiums Ltd
NSE:GOYALALUM
|
IN |
|
Sumuka Agro Industries Ltd
BSE:532070
|
IN |
|
A
|
Acteos SA
PAR:EOS
|
FR |
|
H
|
Haoxin Holdings Ltd
NASDAQ:HXHX
|
CN |
|
M
|
Mitani Sekisan Co Ltd
TSE:5273
|
JP |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
Z
|
Zhejiang Talent Television and Film Co Ltd
SZSE:300426
|
CN |
|
S
|
Shenzhen Anche Technologies Co Ltd
SZSE:300572
|
CN |
Mainz Biomed NV
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The company is headquartered in Mainz, Hessen and currently employs 58 full-time employees. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The company is headquartered in Mainz, Hessen and currently employs 58 full-time employees. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
